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TABLE IV. Percent of lesions improved in 30 psoriasis patients on 
.025% triamcinolone and 1% Ro 20·1724 at2 & 4 weeks 
Triamcinolone-treated 
Ro 20-1724-treated 
2nd Week 
Percent 
4th Week•• 
94° 
77t 
Sign test (one-sided hypothesis) • p = .25, t p < .001. 
" All lesions improved at 2nd week were also improved at 4th week. 
of PUV A cannot be objectively assessed at this time. Ro 20-
1724 and other cyclic nucleotide-altering agents are experimen-
tal agents that may have future potential in the treatment of 
p~o~iasis. Such agents may provide topical therapy with a 
mmunum of adverse side effects which can be used as alterna-
tive forms of treatment for patients with psoriasis who are 
unable to use conventional forms of therapy. 
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ANNOUNCEMENT 
The Center for Disease Control of the Public Health Service is again offering a continuing series of short, 
intensive laboratory training courses during 1979-1980. Information and applications may be obtained from the 
registrar, Bureau of Laboratories, Center for Disease Control, Atlanta, Georgia 30333. 
